Utility of serum interleukin-6 for diagnosis of invasive bacterial disease in children

Tosato, 1988, Monocyte-derived human B-cell growth factor identified as interferon-B2 (BSF-2, IL-6), Science, 239, 502, 10.1126/science.2829354 Hirano, 1985, Purification to homogeneity and characterization of human B cell differentiation factor (BCDF or BSF-2), 82, 5490 Gauldie, 1987, Interferon-beta 2/B-cell stimulatory factor type 2 shares identity with monocyte derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells, 84, 7251 Lotz, 1988, BSF-2/IL-6 is a costimulant for human thymocytes and T lymphocytes, J Exp Med, 167, 1253, 10.1084/jem.167.3.1253 Ikebuchi, 1987, Interleukin-6 enhancement of interleukin-3 dependent proliferation of multipotential hemopoietic progenitors, 84, 9035 Content, 1985, Induction of a 26 kDa-protein mRNA in human cells treated with interleukin-1 related, leukocyte derived factor, Eur J Biochem, 152, 253, 10.1111/j.1432-1033.1985.tb09191.x Kohase, 1986, Induction of beta 2-interferon by tumor necrosis factor: A homeostatic mechanism in the control of cell proliferation, Cell, 45, 659, 10.1016/0092-8674(86)90780-4 Aderka, 1989, IL-6 inhibits lipopolysaccharide-induced tumor necrosis factor production in cultured human monocytes, U937 cells, and in mice, J Immunol, 143, 3517, 10.4049/jimmunol.143.11.3517 Hack, 1989, Increased plasma levels of interleukin-6 in sepsis, Blood, 74, 1704, 10.1182/blood.V74.5.1704.1704 Waage, 1989, The complex pattern of cytokines in serum from patients with meningococcal septic shock, J Exp Med, 169, 333, 10.1084/jem.169.1.333 Calandra, 1991, High circulatory levels of interleukin-6 in patients with septic shock: Evolution during sepsis, prognostic value, and interplay with other cytokines, Am J Med, 91, 23, 10.1016/0002-9343(91)90069-A Bone, 1991, Let's agree on terminology: Definitions of sepsis, Crit Care Med, 19, 973, 10.1097/00003246-199107000-00024 Helfgott, 1989, Multiple forms of IFN-beta 2/IL-6 in serum and body fluids during acute bacterial infection, J Immunol, 142, 948, 10.4049/jimmunol.142.3.948 Ziegler, 1991, Treatment of gram-negative bacteremia and septic shock with HA-IA human monoclonal antibody against endotoxin, N Engl J Med, 324, 429, 10.1056/NEJM199102143240701 Greenman, 1991, A controlled clinical trial of E5 murine monoclonal IgM antibody to endotoxin in the treatment of gram-negative sepsis, JAMA, 266, 1097, 10.1001/jama.1991.03470080067031 Lieu, 1991, Strategies for diagnosis and treatment of children at risk for occult bacteremia: Clinical and cost effectiveness, J Pediatr, 118, 21, 10.1016/S0022-3476(05)81838-4 Ritchie, 1983, Hepatocyte-stimulating factor: A monocyte-derived acute-phase regulatory protein, Ann NY Acad Sci, 408, 490, 10.1111/j.1749-6632.1983.tb23268.x Tracey, 1986, Shock and tissue injury induced by recombinant human cachectin, Science, 234, 470, 10.1126/science.3764421 Tracy, 1987, Cachectin/tumor necrosis factor induces lethal shock and stress hormone responses in the dog, Surg Gynecol Obstet, 164, 415 Okusawa, 1988, Interleukin 1 induces a shock-like state in rabbits, J Clin Invest, 81, 1162, 10.1172/JCI113431 Bell, 1985, Routine quantitative blood cultures in children with Haemophilus influenzae or Streptococcus pneumoniae bacteremia, Pediatrics, 76, 901, 10.1542/peds.76.6.901